“My policy as a doctor was always to be very open and transparent – whether that was about morbidity or mortality I was very open.” In this instalment of the In Vivo podcast, Treehill Partners CEO Ali Pashazadeh focuses on the need for increased communication between biotech and pharma and their contract organizations (both research & development as well as manufacturing organizations).
The discussion also covers how fundamental ethics hold across functions and disciplines.
Listen to the full podcast on: